Other
Development operations
Moderna Development operations decreased by 23.6% to $81M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 32.5%, from $120M to $81M. Over 5 years (FY 2020 to FY 2025), Development operations shows an upward trend with a 29.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2019
Last reportedQ1 2026May 1, 2026
Metric ID:
other_accrued_development_operationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $102M | $125M | $137M | $87M | $65M | $96M | $88M | $98M | $142M | $110M | $140M | $141M | $90M | $80M | $120M | $120M | $108M | $94M | $106M | $81M |
| QoQ Change | — | +22.5% | +9.6% | -36.5% | -25.3% | +47.7% | -8.3% | +11.4% | +44.9% | -22.5% | +27.3% | +0.7% | -36.2% | -11.1% | +50.0% | +0.0% | -10.0% | -13.0% | +12.8% | -23.6% |
| YoY Change | — | — | — | — | -36.3% | -23.2% | -35.8% | +12.6% | +118.5% | +14.6% | +59.1% | +43.9% | -36.6% | -27.3% | -14.3% | -14.9% | +20.0% | +17.5% | -11.7% | -32.5% |
Range$65M – $142M
CAGR-4.7%
Avg YoY Growth+3.4%
Median YoY Growth-13.0%
Frequently Asked Questions
- What is Moderna's development operations?
- Moderna (MRNA) reported development operations of $81M in Q1 2026.
- How has Moderna's development operations changed year-over-year?
- Moderna's development operations decreased by 32.5% year-over-year, from $120M to $81M.
- What is the long-term trend for Moderna's development operations?
- Over 5 years (2020 to 2025), Moderna's development operations has grown at a 29.6% compound annual growth rate (CAGR), from $29M to $106M.